SAN FRANCISCO--(BUSINESS WIRE)--Numerate, Inc., a data-driven drug design company applying artificial intelligence (AI) to transform drug discovery, announced a multi-target research collaboration ...
SAN BRUNO, Calif.--(BUSINESS WIRE)-- Numerate, Inc., a technology platform company that is leveraging proprietary algorithms and the power of cloud computing to radically transform the drug design ...
SAN BRUNO, CA--(Marketwired - Sep 4, 2013) - Numerate, a pioneer in computational drug design, announced today that it has provided its cloud-based BitMill data analytics platform to support the DREAM ...
SAN BRUNO, Calif.--(BUSINESS WIRE)-- Numerate, Inc., a technology platform company that designs drug candidates to meet the specifications of its biotechnology and pharmaceutical partners, announced ...
SAN BRUNO, Calif.--(BUSINESS WIRE)--Numerate, Inc., a computational drug design company applying artificial intelligence (AI) at cloud scale to transform small molecule drug discovery, announced the ...
Computational drug design company Numerate said today it will use its artificial intelligence (AI) platform to identify and deliver multiple clinical candidates for Takeda Pharmaceutical Company, ...
Numerate entered into an agreement with Takeda to use its artificial intelligence engines to develop clinical candidates in multiple specialties. 1. Numerate will identify clinical candidates aimed at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results